Caitriona M. O'driscoll - Publications

The impact of cyclodextrin architecture and charge for optimized nucleic acid delivery: A comparison of monomers, dimers, and polymers.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Published: August 18, 2025

Structure-activity relationship of modified amphiphilic cationic cyclodextrins for enhanced siRNA delivery.

Journal: International journal of pharmaceutics

Published: November 01, 2024

Sialic acid-targeted cyclodextrin-based nanoparticles deliver CSF-1R siRNA and reprogram tumour-associated macrophages for immunotherapy of prostate cancer.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Published: January 17, 2023

Design of lipid-based nanoparticles for delivery of therapeutic nucleic acids.

Journal: Drug discovery today

Published: April 28, 2022

The blood-brain barrier in aging and neurodegeneration.

Journal: Molecular psychiatry

Published: September 02, 2021

Modified cyclodextrin-based nanoparticles mediated delivery of siRNA for huntingtin gene silencing across an in vitro BBB model.

Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V

Published: August 20, 2021

A folate-targeted PEGylated cyclodextrin-based nanoformulation achieves co-delivery of docetaxel and siRNA for colorectal cancer.

Journal: International journal of pharmaceutics

Published: March 10, 2021

Pre-Clinical Evaluation of a Modified Cyclodextrin-Based Nanoparticle for Intestinal Delivery of Liraglutide.

Journal: Journal of pharmaceutical sciences

Published: September 14, 2020

Carcinoembryonic antigen (CEACAM) family members and Inflammatory Bowel Disease.

Journal: Cytokine & growth factor reviews

Published: April 25, 2019

Oral delivery of non-viral nucleic acid-based therapeutics - do we have the guts for this?

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Published: January 17, 2019

The potential for clinical translation of antibody-targeted nanoparticles in the treatment of acute myeloid leukaemia.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: April 28, 2018

Physicochemical, pharmacokinetic and pharmacodynamic analyses of amphiphilic cyclodextrin-based nanoparticles designed to enhance intestinal delivery of insulin.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: March 23, 2018